Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 51Colorectal Neoplasms 44Carcinoma, Hepatocellular 36Rectal Neoplasms 26Lung Neoplasms 23Colonic Neoplasms 22Neoplasm Metastasis 18Esophageal Neoplasms 18Cholangiocarcinoma 15Breast Neoplasms 13Stomach Neoplasms 12Glioma 11Ovarian Neoplasms 10Melanoma 10Carcinoma, Non-Small-Cell Lung 10Carcinoma, Renal Cell 9Anus Neoplasms 9Sarcoma 8Uterine Cervical Neoplasms 7Prostatic Neoplasms 7Medulloblastoma 7Lymphoma, Non-Hodgkin 7Ependymoma 7Carcinoma, Transitional Cell 7Brain Neoplasms 7Adenocarcinoma Of Esophagus 7Wilms Tumor 6Rhabdomyosarcoma 6Rhabdoid Tumor 6Neuroectodermal Tumors, Primitive, Peripheral 6

Interventions

Blood Specimen Collection 6Magnetic Resonance Spectroscopy 4Tenofovir 3Liver Transplantation 3Specimen Handling 2Sorafenib 2Simvastatin 2tremelimumab 1sonidegib 1sofosbuvir-velpatasvir drug combination 1peginterferon alfa-2a 1navitoclax 1maltodextrin 1hepatitis B hyperimmune globulin 1durvalumab 1contrast agent BR1 1bavituximab 1atezolizumab 1apixaban 1adefovir dipivoxil 1Viusid 1Vitamin D 1User-Centered Design 1Surveys and Questionnaires 1Sunitinib 1Spermine Synthase 1Sonazoid 1Sampling Studies 1Radiotherapy 1Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Fibrosis × Magnetic Resonance Spectroscopy × Gastrointestinal × Clear all
NCT02968810 2026-05-29

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

National Cancer Institute (NCI)

Phase 2 Active not recruiting
52 enrolled 15 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT02626312 2026-04-30

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
36 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT07042919 2025-06-29

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Northwestern University

Phase 1/2 Not yet recruiting
53 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT01798173 2022-04-21

CIRCE

Centre Hospitalier Universitaire Dijon

Phase NA Completed
1,246 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡